Publisher： John Wiley & Sons Inc
E-ISSN： 1440-1754|51|6|584-589
ISSN： 1034-4810
Source： JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol.51, Iss.6, 2015-06, pp. : 584-589
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
AbstractMelatonin is a hormone produced by the pineal gland during the night in response to light/dark information received by the retina and its integration by the suprachiasmatic nucleus. When administered to selected populations of adults, in particular those displaying delayed sleep phase disorder, melatonin may advance the time of sleep onset. It is, however, being increasingly prescribed for children with sleep disorders despite the fact that (i) it is not registered for use in children anywhere in the world; (ii) it has not undergone the formal safety testing expected for a new drug, especially long‐term safety in children; (iii) it is known to have profound effects on the reproductive systems of rodents, sheep and primates, as well as effects on the cardiovascular, immune and metabolic systems; and (iv) there is the potential for important interactions with drugs sometimes prescribed for children. In this review, I discuss properties of melatonin outside its ability to alter sleep timing that have been widely ignored but which raise questions about the safety of its use in infants and adolescents.
Related content
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. :
Access to resources
Recommend
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S3, 2015-09 ,pp. :
RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. S3, 2015-12 ,pp. :
By Bogner M. S.
Minimally Invasive Therapy and Allied Technologies, Vol. 12, Iss. 3-4, 2003-07 ,pp. :